LNSR
LENSAR, Inc.
Healthcare — Medical Devices
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Price History
Fundamentals
| Market Cap | $61.53M |
| P/E Ratio (TTM) | - |
| Forward P/E | -7.06 |
| EPS (TTM) | $-0.55 |
| Dividend Yield | - |
| Profit Margin | 50.94% |
| Revenue Growth | -5.20% |
| ROE | 362.55% |
| Debt/Equity | 10.47 |
| Recommendation | None |
| Analyst Target | $8.50 |
| Analysts | 2 |
| Next Earnings | Aug 13, 2026 BMO |
| Indexes | - |
Technical Indicators
| RSI (14) | 13.5 |
| Beta | 0.87 |
| SMA 20 | $5.69 |
| SMA 40 | $5.76 |
| 52-Week High | $13.20 |
| 52-Week Low | $4.95 |
| 50-Day Avg | $5.78 |
| 200-Day Avg | $8.82 |
| Avg Volume | 69.8K |
| Volume | 109.9K |
Performance Analysis
BULLISHLNSR shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Aug 01, 2026 04:16 UTC
Back to Screener Export Report